Induction and maintenance of intravenous anaesthesia using target-controlled infusion systems

Best Practice and Research: Clinical Anaesthesiology

Volumn 15, Issue 1, 2001, Pages 19-33

  Viviand, Xavier ^a   Léone, Marc ^a  

^a HÔPITAL NORD   (France)

Author keywords

Anaesthetic techniques; Computer simulation; Intravenous infusion; Pharmacodynamics; Pharmacokinetics; Target controlled infusion

Indexed keywords

ALFENTANIL; ETOMIDATE; FENTANYL; HYPNOTIC AGENT; INTRAVENOUS ANESTHETIC AGENT; KETAMINE; METHOHEXITAL; MIDAZOLAM; MUSCLE RELAXANT AGENT; OPIATE DERIVATIVE; PROPOFOL; REMIFENTANIL; SUFENTANIL; TEMAZEPAM; THIOPENTAL;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANESTHESIST; AROUSAL; CLINICAL TRIAL; COMPUTER SIMULATION; CONTINUOUS INFUSION; CONVALESCENCE; DRUG CLEARANCE; DRUG COST; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HEALTH CARE COST; HEMODYNAMICS; HUMAN; HYPOTENSION; INFUSION SYSTEM; INTRAVENOUS ANESTHESIA; PAIN; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; REVIEW; SAFETY; SEDATION; SYRINGE; VAPORIZER; WORKLOAD;

EID: 0034960596     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2001.0133     Document Type: Article

References (78)

1. Why total intravenous anaesthesia (TIVA)?
2. Total intravenous anesthesia
3. Intravenous anesthesia and analgesia: What is the role of target-controlled infusion?
4. Minimal alveolar anesthetic concentration: A standard of anesthetic potency
5. Propofol blood concentration and the bispectral index predict suppression of learning during propofol/epidural anesthesia in volunteers
6. Comparison of the effect-site k(eO)s of propofol for blood pressure and EEG bispectral index in elderly and younger patients
7. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients
8. Rate-dependent induction phenomena with propofol: Implications for the relative potency of intravenous anesthetics
9. Effect of different rates of infusion of propofol for induction of anaesthesia in elderly patients
10. Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia
11. Continuous intravenous infusion and multicompartment accumulation
12. A general method for calculating the dosage scheme in linear pharmacokinetics
13. Measuring the predictive performance of computer-controlled infusion pumps
14. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion
15. Pharmacokinetic model driven infusion of propofol in children
16. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets
17. Computer-controlled infusion of propofol for long neurosurgical procedures
18. Performance of computer-controlled infusion of propofol: An evaluation of five pharmacokinetic parameter sets
19. Population pharmacokinetics of propofol. A multicenter study
20. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump
21. Pharmacokinetic model-driven infusion of fentanyl: Assessment of accuracy
22. Predictive accuracy of continuous alfentanil infusion in volunteers: Variability of different pharmacokinetic sets
23. Predictive accuracy of target-controlled propofol and sufentanil coinfusion in long-lasting surgery
24. Population pharmacokinetics of midazolam administered by target-controlled infusion for sedation following coronary artery bypass grafting
25. Target-controlled infusion of ketamine as analgesia for TIVA with propofol
26. The combined effect of age and premedication on the propofol requirements for induction by target-controlled infusion
27. Induction of anaesthesia with midazolam and a target-controlled propofol infusion
28. Induction of anesthesia with propofol using a target-controlled infusion system
29. 50 of propofol for loss of consciousness and skin incision
30. Pharmacodynamics of propofol in female patients
31. A physiological model of induction of anaesthesia with propofol in sheep. 2. Model analysis and implications for dose requirements
32. Performance of computer-assisted continuous infusion at low concentrations of intravenous sedatives
33. Pharmacodynamic interaction between propofol and alfentanil when given for induction of anesthesia
34. Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
35. Pharmacokinetics, pharmacodynamics, and rational opioid selection
36. Propofol concentration required for endotracheal intubation with a laryngoscope or fiberscope and its interaction with fentanyl
37. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction
38. The arterial blood propofol concentration preventing movement in 50% of healthy women after skin incision
39. 50 of propofol with and without nitrous oxide
40. Effective concentrations 50 for propofol with and without 67% nitrous oxide
41. Propofol anesthesia and rational opioid selection: Determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness
42. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs
43. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women
44. Awakening propofol concentration with and without blood-effect site equilibration after short-term and long-term administration of propofol and fentanyl anesthesia
45. Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery
46. TCI compared with manually controlled infusion of propofol: A multicentre study
47. Awake tracheal intubation with the intubating laryngeal mask in a patient with diffuse idiopathic skeletal hyperostosis
48. Comparison of propofol administration techniques for sedation during monitored anesthesia care
49. Sedation with propofol during surgery under local blockade. Assessment of a target-controlled infusion system
50. Patient-maintained propofol sedation as premedication in day-case surgery: Assessment of a target-controlled system
51. Propofol anesthesia for colonoscopy: Comparison of manual administration with target control infusion
52. An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil
53. Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: Comparison with a manual method
54. Comparison of computer-controlled administration of propofol with two manually controlled infusion techniques
55. Manual compared with target-controlled infusion of propofol
56. Safety and efficacy of target controlled infusion (Diprifusor) vs manually controlled infusion of propofol for anaesthesia
57. Assessment of the value and pattern of use of a target controlled propofol infusion system
58. Target controlled infusion (TCI) anaesthesia using propofol. Assessment of training and practice in the operating room
59. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers
60. The influence of age on propofol pharmacodynamics
61. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development
62. The effect of rate of administration on brain concentrations of propofol in sheep
63. The pharmacokinetics of propofol in children using three different data analysis approaches
64. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns
65. The pharmacokinetics of alfentanil in children
66. Does size matter?
67. Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations
68. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump
69. Patient-maintained remifentanil target-controlled infusion for the transition to early postoperative analgesia
70. Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans
71. Closed-loop control of propofol anaesthesia
72. Closed-loop administration of propofol using bispectral index
73. Bayesian forecasting improves the prediction of intraoperative plasma concentrations of alfentanil
74. Algorithm to control `effect-compartment' drug concentration in pharmacokinetic model-driven drug delivery
75. Targeting effect compartment of central compartment of propofol. What predicts loss of consciousness?
76. Comparison of plasma compartment versus two methods for effect compartment-controlled target infusion for propofol
77. Computer-controlled infusion of alfentanil for postoperative analgesia. A pharmacokinetic and pharmacodynamic evaluation
78. Patient-maintained analgesia with target-controlled alfentanil infusion after cardiac surgery: A comparison with morphine PCA